Mpa2l Activators
Mpa2l Activators are a collection of chemical entities that are known to modulate various signaling pathways, which can lead to an enhancement of Mpa2l's functional activity. Compounds such as Forskolin and Isobutylmethylxanthine (IBMX) operate by elevating intracellular cAMP levels and inhibiting phosphodiesterases, respectively, both culminating in the activation of protein kinase A (PKA). PKA, in turn, can phosphorylate substrates that may interact with Mpa2l, thus enhancing its activation. Similarly, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate targets within the signaling pathways thatinvolve Mpa2l, potentially boosting its role. Furthermore, Epigallocatechin gallate (EGCG) and Genistein, by inhibiting various kinases, can diminish competitive signaling and thereby facilitate the pathways in which Mpa2l is active. The lipid signaling molecule Sphingosine-1-phosphate (S1P) and the PI3K inhibitor LY294002 both contribute to the modulation of complex signaling cascades that can indirectly enhance Mpa2l activity by impacting related molecules or processes.
The functional activity of Mpa2l is also influenced by compounds that affect MAPK signaling and calcium homeostasis. U0126 and SB203580, by specifically inhibiting MEK1/2 and p38 MAPK respectively, alter the balance of cellular signaling in such a way that could favor Mpa2l activation. A23187 and Thapsigargin, by increasing intracellular calcium levels through different mechanisms, support the activation of calcium-dependent pathways that Mpa2l might be a part of. Lastly, Staurosporine, despite its general kinase inhibition properties, could indirectly foster the activation of Mpa2l by repressing kinases that negatively regulate pathways relevant to Mpa2l's function. Collectively, these Mpa2l Activators, through their targeted modulation of various biochemical pathways, serve to enhance the functional activity of Mpa2l without necessitating a direct increase in its expression or direct binding and activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, enzymes that break down cAMP and cGMP. By preventing the degradation of cAMP, IBMX can indirectly perpetuate PKA activation, which may enhance the functional activity of Mpa2l. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of target proteins, possibly enhancing the functional activity of Mpa2l through downstream effects on the signaling cascades it is involved in. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is a polyphenol that acts as an antioxidant and has been shown to inhibit certain kinases. By inhibiting competitive kinase pathways, EGCG could indirectly enhance the signaling pathways in which Mpa2l is active. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is a lipid signaling molecule that can activate G protein-coupled receptors, leading to downstream signaling events. S1P may enhance the functional activity of Mpa2l by modulating signaling pathways that include G protein-coupled receptor targets. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, which can alter the activity of downstream signaling pathways, such as AKT. By modulating this pathway, LY294002 could indirectly enhance the activation of Mpa2l by affecting related signaling molecules. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which are part of the MAPK/ERK pathway. By inhibiting MEK1/2, U0126 may indirectly enhance the activity of Mpa2l by shifting the signaling equilibrium towards pathways where Mpa2l is functionally active. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. Elevated calcium can activate various calcium-dependent kinases and phosphatases, potentially enhancing the activity of Mpa2l through calcium signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can modulate signaling pathways by reducing kinase activity. By inhibiting tyrosine kinases, Genistein may enhance pathways where Mpa2l is involved by reducing competition from tyrosine kinase signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels. This rise in calcium can trigger calcium-dependent signaling cascades, which can enhance the functional activity of Mpa2l. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK. By inhibiting p38, it may shift signaling dynamics to favor the activation of Mpa2l through alternative pathways that do not rely on p38 MAPK activity. | ||||||